PubRank

George F Sawaya

Author PubWeight™ 56.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. Ann Intern Med 2009 2.86
2 Screening interval and risk of invasive squamous cell cervical cancer. Obstet Gynecol 2003 2.19
3 Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study. J Natl Cancer Inst 2009 2.17
4 Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women. Menopause 2009 2.07
5 NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements 2013 1.81
6 Association between cancer risk perception and screening behavior among diverse women. Arch Intern Med 2008 1.70
7 USPSTF recommendations for STI screening. Am Fam Physician 2008 1.68
8 HPV vaccination--more answers, more questions. N Engl J Med 2007 1.64
9 Cervical Cancer Screening in Average-Risk Women: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med 2015 1.63
10 MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial. Menopause 2009 1.63
11 Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoS One 2010 1.55
12 Routine bimanual pelvic examinations: practices and beliefs of US obstetrician-gynecologists. Am J Obstet Gynecol 2012 1.52
13 Evidence-based medicine versus liquid-based cytology. Obstet Gynecol 2008 1.43
14 Reconsidering the criteria for evaluating proposed screening programs: reflections from 4 current and former members of the U.S. Preventive services task force. Epidemiol Rev 2011 1.33
15 Persistent hot flushes in older postmenopausal women. Arch Intern Med 2008 1.28
16 Frequency and severity of hot flashes and sleep disturbance in postmenopausal women with hot flashes. Menopause 2009 1.23
17 Current cervical neoplasia screening practices of obstetrician/gynecologists in the US. Am J Obstet Gynecol 2005 1.18
18 Cervical cancer screening intervals, 2006 to 2009: moving beyond annual testing. JAMA Intern Med 2013 1.17
19 Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trial. Obstet Gynecol 2007 1.10
20 Willingness to use tamoxifen to prevent breast cancer among diverse women. Breast Cancer Res Treat 2012 1.10
21 Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests. Obstet Gynecol 2006 1.09
22 Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. Obstet Gynecol 2003 1.07
23 Discontinuation of postmenopausal hormone therapy. Am J Med 2005 1.05
24 Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe. Sex Transm Dis 2009 1.03
25 Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women. J Gen Intern Med 2008 1.03
26 Pelvic examinations and access to oral hormonal contraception. Obstet Gynecol 2010 1.01
27 Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic review. Am J Obstet Gynecol 2009 0.97
28 Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness. Obstet Gynecol 2010 0.89
29 Using visual displays to communicate risk of cancer to women from diverse race/ethnic backgrounds. Patient Educ Couns 2012 0.87
30 Defining competencies for education in health care value: recommendations from the University of California, San Francisco Center for Healthcare Value Training Initiative. Acad Med 2015 0.86
31 Cervical cancer screening continues to limit provision of contraception. Contraception 2005 0.86
32 Treatment patterns for cervical carcinoma in situ in Michigan, 1998-2003. J Registry Manag 2013 0.81
33 Adding human papillomavirus testing to cytology for primary cervical cancer screening: shooting first and asking questions later. Ann Intern Med 2008 0.81
34 Changes to cervical cancer prevention guidelines: effects on screening among U.S. women ages 15-29. Prev Med 2012 0.81
35 New guidelines: it's complicated. Obstet Gynecol 2013 0.80
36 Oophorectomy as a risk factor for coronary heart disease. Am J Obstet Gynecol 2008 0.80
37 Updated recommendations for breast cancer screening. Curr Opin Obstet Gynecol 2010 0.79
38 Investigating Potential Associations between Cervical Procedures and HIV Acquisition. ISRN Obstet Gynecol 2011 0.78
39 Is there an association between HIV-1 genital shedding and cervical intraepithelial neoplasia 2/3 among women on antiretroviral therapy? J Low Genit Tract Dis 2013 0.78
40 Trials that matter: liquid-based cervical cytology: disadvantages seem to outweigh advantages. Ann Intern Med 2007 0.77
41 Receipt of cervical cancer screening in female veterans: impact of posttraumatic stress disorder and depression. Womens Health Issues 2013 0.77
42 Testing for human papillomavirus in women with abnormal pap smear results. JAMA 2002 0.75
43 Association of cervical biopsy with HIV type 1 genital shedding among women on highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2013 0.75
44 The new mammographic screening guidelines: what were they thinking? Obstet Gynecol 2010 0.75
45 Screening pelvic examinations: right, wrong, or rite? Ann Intern Med 2014 0.75
46 Update on quadrivalent human papillomavirus vaccination and pregnancy outcomes: is contraception advisable? Obstet Gynecol 2009 0.75
47 Papanicolaou testing: when does more become less? Am J Med 2005 0.75
48 Cervical cancer screening among women without a cervix. JAMA 2004 0.75
49 Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay. Obstet Gynecol 2011 0.75
50 Effect of Replens gel used with a diaphragm on tests for human papillomavirus and other lower genital tract infections. J Low Genit Tract Dis 2006 0.75
51 Human Immunodeficiency Virus (HIV)- and Non-HIV-Associated Immunosuppression and Risk of Cervical Neoplasia. Obstet Gynecol 2017 0.75
52 Stage at diagnosis and mortality in patients with adenocarcinoma and adenosquamous carcinoma of the uterine cervix diagnosed as a consequence of cytologic screening. Acta Cytol 2003 0.75